Interrogating JAK/STAT signaling in ovarian cancer as a potential oncogenic driver and therapeutic target

被引：0
|
作者：
Rodman, Esther [1 ]
Emch, Michael [1 ]
Bruinsma, Elizabeth [1 ]
Hou, Xiaonan [1 ]
Weroha, John [1 ]
Hawse, John [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1129
引用
收藏
页数：1
相关论文
共 50 条
  • [21] LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer
    Tang, Weiwei
    Ramasamy, Kumaraguruparan
    Pillai, Sureshkumar M. A.
    Santhamma, Bindu
    Konda, Swapna
    Venkata, Prabhakar Pitta
    Blankenship, Logan
    Liu, Junhao
    Liu, Zexuan
    Altwegg, Kristin A.
    Ebrahimi, Behnam
    Pratap, Uday P.
    Li, Xiaonan
    Valente, Philip T.
    Kost, Edward
    Sareddy, Gangadhara R.
    Vadlamudi, Ratna K.
    Nair, Hareesh B.
    Tekmal, Rajeshwar R.
    Viswanadhapalli, Suryavathi
    CELL DEATH DISCOVERY, 2021, 7 (01)
  • [22] LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer
    Weiwei Tang
    Kumaraguruparan Ramasamy
    Sureshkumar M. A. Pillai
    Bindu Santhamma
    Swapna Konda
    Prabhakar Pitta Venkata
    Logan Blankenship
    Junhao Liu
    Zexuan Liu
    Kristin A. Altwegg
    Behnam Ebrahimi
    Uday P. Pratap
    Xiaonan Li
    Philip T. Valente
    Edward Kost
    Gangadhara R. Sareddy
    Ratna K. Vadlamudi
    Hareesh B. Nair
    Rajeshwar R. Tekmal
    Suryavathi Viswanadhapalli
    Cell Death Discovery, 7
  • [23] Rac1 as a driver and therapeutic target in ovarian cancer.
    Rivera, Melanie
    Grimes, Martha M.
    Hudson, Laurie G.
    Wandinger-Ness, Angela
    CANCER RESEARCH, 2021, 81 (13)
  • [24] The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma
    Ou, Alexander
    Ott, Martina
    Fang, Dexing
    Heimberger, Amy B.
    CANCERS, 2021, 13 (03) : 1 - 25
  • [25] STAT3 is a potential therapeutic target in cervical cancer
    Kohut, Adrian
    Martincuks, Antons
    Santiago, Nicole Lugo
    Austria, Theresa
    Zhao, Qianqian
    Lee, Stephen
    Tergas, Ana
    Dellinger, Thanh
    Han, Ernest
    Rodriguez-Rodriguez, Lorna
    Yu, Hua
    Song, Mihae
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S137 - S138
  • [26] Exploiting JAK/STAT signaling to inhibit highly advanced and resistant forms of ovarian cancer
    Rodman, Esther
    Emch, Michael
    Bajaj, Archit
    Tang, Xiaojia
    Hou, Xiaonan
    Kaufmann, Scott
    Kalari, Krishna
    Weroha, John
    Hawse, John
    CANCER RESEARCH, 2024, 84 (05)
  • [27] Investigation of the JAK/STAT signaling pathway in chemotherapy and PARP inhibitor resistant ovarian cancer
    Rodman, Esther
    Emch, Michael
    Bruinsma, Elizabeth
    Hou, Xiaonan
    Kaufmann, Scott
    Weroha, Saravut J.
    Hawse, John
    CANCER RESEARCH, 2023, 83 (07)
  • [28] Neurotensin signaling pathway as a potential therapeutic target in high-grade serous ovarian cancer
    Norris, E. J.
    DeStephanis, D.
    Zhang, Q.
    Tait, D. L.
    Ganapathi, R.
    Ganapathi, M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 71 - 71
  • [29] Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells
    Guo, Shanchun
    Liu, Mingli
    Wang, Guangdi
    Torroella-Kouri, Marta
    Gonzalez-Perez, Ruben R.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2012, 1825 (02): : 207 - 222
  • [30] NFKB SIGNALING PATHWAY AS A THERAPEUTIC TARGET IN CHEMORESISTANT OVARIAN CANCER
    Yousefi, H.
    Momeny, M.
    Poursheykhani, A.
    Ghaffari, S. H. A.
    Eyvani, H.
    Zarrinrad, G.
    Barghi, F.
    Sabourinejad, Z.
    Esmaili, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1727 - 1727
12345